Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lamivudine/stavudine vs lamivudine/zidovudine in HIV-negative volunteers

Trial Profile

Lamivudine/stavudine vs lamivudine/zidovudine in HIV-negative volunteers

Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2013

At a glance

  • Drugs Lamivudine/stavudine (Primary) ; Lamivudine/zidovudine (Primary)
  • Indications HIV infections
  • Focus Adverse reactions; Pharmacodynamics
  • Acronyms SAMA001
  • Most Recent Events

    • 28 Mar 2013 New trial record
    • 06 Mar 2013 Pooled analysis of bone turnover markers presented at the 20th Conference on Retroviruses and Opportunistic Infections.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top